Page 6 - Oche News Today

Swiss multinational healthcare company, Roche, has terminated its worldwide license and collaboration agreement with Repare Therapeutics despite the company earning a $40 million milestone payment from Roche.

LONDON/FRANKFURT (Reuters) -Roche forecast a pick up in sales growth this year as it overcomes a slump in demand for its COVID-19 products and a decline in sales of a trio of established cancer drugs abates. Sales in 2023 rose 1% to 58.7 billion Swiss francs ($68 billion), slightly below analysts' average estimate of closer to 60 billion francs, according to LSEG data. CEO Thomas Schinecker told reporters it was a "significant achievement" that the company increased sales despit...

Vabysmo sustained robust drying of retinal fluid, often associated with distorted or blurry vision Up to 60% of people receiving Vabysmo were able to...

Swiss pharmaceutical company Roche announced net income was down but it expects mid single-digit sales increase for 2024. Roche reported that its International Financial Reporting Standards (IFRS) net income for fiscal year 2023 declined about 9% to 12.36 billion Swiss francs from 13.53 billion francs last year. But IFRS net income increased by 7% at constant exchange rates (CER) due to the increase in operating profit and lower income tax expenses. Core earnings per share was 18.57 francs down

Chemed Co. (NYSE:CHE – Get Free Report) was the recipient of a significant drop in short interest in the month of January. As of January 15th, there was short interest totalling 422,500 shares, a drop of 6.3% from the December 31st total of 450,900 shares. Based on an average trading volume of 78,200 shares, the […]

Clinical-stage precision oncology company, Repare Therapeutics Inc., has received a $40 million milestone payment from Roche after dosing the first patient in a clinical trial.

EverSource Wealth Advisors LLC reduced its position in Chemed Co. (NYSE:CHE – Free Report) by 4.0% during the third quarter, HoldingsChannel.com reports. The firm owned 481 shares of the company’s stock after selling 20 shares during the period. EverSource Wealth Advisors LLC’s holdings in Chemed were worth $250,000 at the end of the most recent […]

Larson Financial Group LLC purchased a new position in shares of Chemed Co. (NYSE:CHE – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 84 shares of the company’s stock, valued at approximately $44,000. A number of other institutional investors have […]

Steppenwolf Theatre Company has revealed new details, including full casting, for its now-titled world premiere of Little Bear Ridge Road.

Raymond James Financial Services Advisors Inc. trimmed its stake in Chemed Co. (NYSE:CHE – Free Report) by 26.6% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,481 shares of the company’s stock after selling 536 shares during the quarter. Raymond James […]